Medicare has selected the technology vendors who'll run its prior authorization pilot in New Jersey, Ohio, Oklahoma, Texas, ...

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry ...

On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...

A federal judge in Rhode Island ordered the Trump administration Thursday to find the money to fully fund SNAP benefits for ...

The FDA announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to ...

Leading scientists and bioethicists are urging the creation of an international oversight body to monitor advances in human ...

RFK Jr. has railed against drugmakers but he struck a different tone in commenting on President Trump's deal to expand access to obesity drugs ...

Pfizer is preparing to sweeten its offer again for Metsera, the weight loss drug startup at the center of a bidding war with ...

If Congress does extend the enhanced subsidies into next year, policymakers and insurance companies can do a few things to ...

Biotech investors have not often looked at a balding head of hair and been struck with inspiration, even on the rare ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

Morning! Join us later today for a virtual event with STAT’s Jason Mast and Damian Garde about the past and future of Moderna ...